THE-NAGA-GROUP-AG
20.5.2020 15:00:06 CEST | Business Wire | Press release
The NAGA Group continues its high growth rate and announces new projects.
With NAGA Pay, NAGA will be launching its own challenger bank app, which for the first time combines mobile banking, trading, social trading and cryptocurrency trading.
"NAGA Pay is an ambitious project with great growth potential. In recent years we have gained a lot of experience in building a real-time trading platform with a clear monetization model across a wide range of asset classes. Our trading app and our cryptocurrency platform have processed millions of transactions. In parallel, our NAGA Card programme, which offers our customers a prepaid Mastercard and a European IBAN account, has shown very promising growth rates. We have also followed the projects in the multi-billion NEO-Banking / Challenger-Bank segment very closely and have created all the prerequisites to become part of this segment. Hence, we have decided to combine all our expertise in NAGA Pay and are currently developing a super app for mobile banking and investing. The entry into the payment vertical underlines the FinTech character of our company and will offer us new customer acquisition and growth opportunities without losing our focus on the core business", says Benjamin Bilski, founder and CEO of The NAGA Group AG.
NAGA Pay will be launched around the beginning of Q4 2020 as a separate native iOS- and Android app. The app combines the offer of a prepaid credit card, a European IBAN bank account with limits of up to € 200,000 per year and complete banking functions such as SEPA transfers. In addition to real-time money transfers and money management, NAGA customers can trade over 400 stocks from 9 global stock exchanges free of charge, as well as copy other top traders with one click. The offer is completed with the integration of the NAGA Wallet and NAGAX, so that customers can buy and sell physical cryptocurrencies with NAGA Pay and make blockchain-based deposits and withdrawals.
For more information and to register to the NAGA Pay waiting list https://www.naga.com/pay has been launched today.
Furthermore, NAGA is delighted to announce the launch of NAGA Pro. NAGA Pro is aimed specifically at users who already run their own financial trading community, are pursuing a career as a professional trader or want to build a business model in the trading space. NAGA-Pro offers its users a monthly base remuneration and a lucrative performance package if certain criteria are met, thereby creating a unique "digital influencer" model.
"NAGA Pro is a real growth catalyst for us. Due to the high level of investment in our own trading platform and our cooperation with 600,000 users and 1,500 partners, we understand the needs of users as well as professional traders, trainers and operators in the wider trading and investing world. We see this as a slight adjustment in our business model and positioning. Instead of plunging into the very expensive and "innovation-free" marketing battle for retail customers, we want to use our technology offer in a focused manner by helping entrepreneurs and businesses accelerate their growth and ultimately to grow together with us. In a nutshell, NAGA Pro is a tool for traders, professionals, and for all those with business models focused around trading who bring their community and followers with them or build up a community within NAGA. Thereby we will differentiate ourselves from the competition and expand our marketing and sales focus accordingly", commented Bilski.
The NAGA Pro model is already successfully practiced at NAGA. With pilot projects in Asia and Poland that started at the beginning of the year, over 30% of the total turnover can be attributed to the NAGA Pro pilots.
"Our unique selling point as the most innovative and user-friendly platform on the market is underpinned by NAGA Pro. The proof of concept has been delivered. We therefore see ourselves in the highly encouraging situation of being able to offer a "Platform-as-a-Service" or, as our NAGA Pro users say so nicely - "The Uber model for investing" - which is aimed at the operator and not only at the end user", adds Benjamin Bilski.
Further information on NAGA Pro can be found on the dedicated website naga.com/pro .
Finally, the company reports the preliminary results of April and the start of the project in China.
In April, NAGA achieved a strong revenue result of around € 2.2 million and a preliminary net profit of around € 0.6 million and therefore continued the strong growth and earnings momentum built in Q1 (Q1: revenues € 7.0 million, net profit €2.1m). In addition, a new record number of registrations was recorded in April, which can be seen as the foundation for further growth. NAGA is also delighted to report that the first transactions of the NAGA China project were processed during May, with management expecting further growth in the course of Q3 and especially Q4.
"We are fully dedicated to growth, we want to keep the momentum high and continue to show how much potential there is in NAGA's unique platform and our business model. Another focus of the next few months will be the optimization of acquisition costs, sustainable growth and, above all, the addition of new personnel, as we have just posted around 30 new vacancies," concludes Benjamin Bilski.
###
About NAGA
NAGA is an innovative fintech company that has developed a socially enhanced financial system that creates a unified and seamless experience across personal finance and investing. Its proprietary platform offers a range of products ranging from trading, investing, and cryptocurrencies to a physical Mastercard and social investing features such as a Feed, a Messenger and Auto-Copy. NAGA is a synergistic all-in-one solution that's accessible and inclusive, and that provides a better way to trade, invest, connect, earn, acquire and pay, across both fiat and crypto.
| Language: | English |
| Company: | The NAGA Group AG |
| Hohe Bleichen 12 | |
| 20354 Hamburg | |
| Germany | |
| E-mail: | info@naga.com |
| Internet: | www.naga.com |
| ISIN: | DE000A161NR7 |
| WKN: | A161NR |
| Indices: | Scale 30 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Munich, Stuttgart, Tradegate Exchange |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200520005489/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom